A business in context
GILD research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-08-17 | Mercier Johanna | M · Exercise / conversion | Non-qualified Stock Option (Right to Buy) | 23110.0 | 0.0 |
| 2026-08-17 | Dickinson Andrew D | S · Sale | Common Stock | 3000.0 | 138.36 |
| 2026-08-10 | Cain Wettan Keeley M | F · Tax / exercise payment | Common Stock | 2908.0 | 133.06 |
| 2026-08-10 | Cain Wettan Keeley M | M · Exercise / conversion | Common Stock | 6002.0 | n/a |
| 2026-08-10 | Cain Wettan Keeley M | M · Exercise / conversion | Restricted Stock Unit | 6002.0 | n/a |
| 2026-08-03 | O'Day Daniel Patrick | S · Sale | Common Stock | 6700.0 | 129.66 |
| 2026-08-03 | O'Day Daniel Patrick | S · Sale | Common Stock | 600.0 | 131.34 |
| 2026-08-03 | O'Day Daniel Patrick | S · Sale | Common Stock | 7700.0 | 130.8 |
| 2026-07-15 | Mercier Johanna | S · Sale | Common Stock | 3000.0 | 129.92 |
| 2026-07-15 | Dickinson Andrew D | S · Sale | Common Stock | 3000.0 | 129.93 |
| 2026-07-01 | O'Day Daniel Patrick | S · Sale | Common Stock | 11900.0 | 126.09 |
| 2026-07-01 | O'Day Daniel Patrick | S · Sale | Common Stock | 3100.0 | 127.08 |
Identity & relationships
SEC issuer · 0000882095GILEAD SCIENCES, INC.
Gilead Sciences LtdGilead Sciences (Australia)Kite Pharma
- Legal Entity Identifier
- 549300WTZWR07K8MNV44
- GLEIF legal name
- GILEAD SCIENCES, INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-03-03T10:10:30Z
Search names and former names
View Wikidata identity and references ↗
- Gilead Sciences · alias · wikidata
- Gilead · alias · wikidata
- Gilead Sciences Ltd · subsidiary · wikidata
- NEXSTAR PHARMACEUTICALS LIMITED · subsidiary · wikidata
- VESTAR LIMITED · subsidiary · wikidata
- MAPLESTORE LIMITED · subsidiary · wikidata
- Gilead Sciences (Australia) · subsidiary · wikidata
- Kite Pharma · subsidiary · wikidata
- Kite Pharma Inc · subsidiary · wikidata
- GILEAD SCIENCES INC · former SEC name · 1994-02-14 to 2022-02-17
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $28.75B | $30.88B |
| 2023-12-31 | $27.12B | $29.98B |
| 2022-12-31 | $27.28B | $31.40B |
| 2021-12-31 | $27.30B | $33.95B |
| 2020-12-31 | $24.69B | $32.14B |
| 2019-12-31 | $22.45B | $29.58B |
| 2018-12-31 | $22.13B | $29.69B |
| 2017-12-31 | $26.11B | $35.89B |